ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Nutriband Inc. Signs Acquisition Agreement of Carmel Biosciences and FDA Approved Prexxartan™
September 28, 2018Nutriband Inc., is pleased to announce it has signed the definitive acquisition agreement to acquire Carmel Biosciences, Inc. The acquisition is expected to be valued at approximately $2,700,000 and will be paid in company stock in the amount of 350,000
Pharma Sources Insight January 2025
